Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Entero Therapeutics, Inc. (GRDX) had Return on Investments of -1.08% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.24M |
|
-- |
|
-- |
|
$0.93M |
|
$-0.93M |
|
$-0.04M |
|
$-0.97M |
|
$-0.97M |
|
$-0.97M |
|
$-0.97M |
|
$-1.15M |
|
$-0.97M |
|
$-0.93M |
|
$-0.93M |
|
1.65M |
|
1.65M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$87.70M |
|
$0.03M |
|
$47.67M |
|
$135.37M |
|
$33.52M |
|
-- |
|
$12.29M |
|
$45.81M |
|
$27.88M |
|
$44.60M |
|
$89.56M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-1.73M |
|
$0.34M |
|
$3.73M |
|
$0.18M |
|
$2.52M |
|
$2.33M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.48% |
|
-2.18% |
|
-0.72% |
|
|
Return on Investments |
-1.08% |
$35.16 |
|
$-1.05 |
|
$-1.05 |
|